49 web-programmer-developer-"https:"-"UCL"-"https:" Postdoctoral positions at Nature Careers in United States
Sort by
Refine Your Search
-
platforms. In addition to mechanistic studies, the lab also specializes in the discovery and development of drugs for the treatment of diabetes and obesity. Our research program is well funded by National
-
: the NIH, Pew Biomedical Foundation, and the Cystic Fibrosis Foundation to develop novel approaches to engineer programmable transposons for clinical gene replacement therapy. The Kellogg lab is a highly
-
, cancer or genomics. Specific experience in mouse models and hematopoietic development are a plus. St. Jude Children's Research Hospital is a world-class research institution dedicated to pediatric cancer
-
-640; Gastroenterology 2021 Jul 8:S0016-5085(21)03159-0; Nature Reviews Cancer 2023 Mar 27:1-20, Nature Cell Biology, 2024 May;26(5):840). Our program is well-funded by NCI, with multiple R01 grants and
-
, or medicinal and analytical chemistry. These positions present exceptional opportunities to partner with an outstanding clinical urology program in a new institute dedicated to rapidly translating basic
-
-640; Gastroenterology 2021 Jul 8:S0016-5085(21)03159-0; Nature Reviews Cancer 2023 Mar 27:1-20, Nature Cell Biology, 2024 May;26(5):840). Our program is well-funded by NCI, with multiple R01 grants and
-
Alzheimer’s disease to develop and/or apply computational approaches to large scale genomic or transcriptomic datasets for identification of targets for early detection, prevention or treatment of Alzheimer’s
-
The Ghezzi Lab at University of Massachusetts Lowell is looking for a full-time, fully benefitted Postdoctoral Research Associate to participate in a NIH-funded research program which aims
-
increasing independence over time. Collaborate on project and analysis design guided by their PI. Develop new computational methods. Adhere to field and lab standards for data analysis. Identify, process
-
IL-1R/TLR axis in pancreatic adenocarcinoma models. The overarching goal of our research is to develop novel therapeutic regimens that can be advanced into clinical trials for cancer patients